Juvantia Pharma

Juvantia is a Finnish pharmaceutical R&D company founded in April 1997. The first Product Concept of Juvantia is a novel adjunct to treatment of Parkinson's disease, entering clinical studies in the beginning of 1999. Juvantia Pharma Ltd offers for world-wide licensing rights to its international patent on solid-support chemistry. The patented innovation (US, PCT, plus three other countries) is on a method for preparation of tertiary amines on solid support.

Activity:

Product / Technology type(s) covered:

- API / chemicals
- Pharmaceuticals / Therapeutics

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: